SCHEMBL5651907

SCHEMBL5651907

O=C(O)c1sc(-c2ccccc2)cc1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.55
PTPRF P10586 1/20 0.55
MAPT P10636 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
POLB P06746 1/20 0.54
CRHBP P24387 1/20 0.54
CRHR2 Q13324 1/20 0.54
IKBKB O14920 4/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
BTK Q06187 1/20 0.53
KDM4E B2RXH2 2/20 0.51
LMNA P02545 1/20 0.51
PKM P14618 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
ALDH1A1 P00352 2/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14367853 0.84 MKNK1 (0.55) PTPN1CYP1A2CYP3A4CYP2C9ALDH1A1
Hydrochloric Acid SCHEMBL5653571 0.82 MKNK1 (0.54) PTPN1CYP1A2CYP3A4CYP2C9ALDH1A1
SCHEMBL13118033 0.80 MAPT (0.39) PTPN1PTPRFMAPTMEN1KMT2A
SCHEMBL13004629 0.79 XDH (0.46) PTPN1PTPRFMAPTMEN1KMT2A
SCHEMBL3585269 0.78 KDM4E (0.56) PTPN1PTPRFMAPTMEN1KMT2A
SCHEMBL2158793 0.78 PTPRF (0.55) PTPN1PTPRFMAPTMEN1KMT2A
SCHEMBL2044907 0.78 IKBKB (0.77) PTPN1PTPRFMAPTMEN1KMT2A
SCHEMBL17201623 0.77 ADORA1 (0.39) PTPN1PTPRFMAPTMEN1KMT2A
SCHEMBL2158576 0.76 IKBKB (0.75) PTPN1PTPRFMAPTMEN1KMT2A
SCHEMBL2248681 0.75 IKBKB (0.60) PTPN1PTPRFMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070270458-A1 Nicotinic Acetylcholine Receptor Ligands ASTRAZENECA AB (SE) 2007-11-22 US disclosed
CN-1914201-A Nicotinic acetylcholine receptor ligands ASTRAZENECA AB (SE) 2007-02-14 CN disclosed
EP-1699786-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AstraZeneca AB (SE) 2006-09-13 EP disclosed
WO-2005061494-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2005-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270458-A1 Nicotinic Acetylcholine Receptor Ligands CHRNA2, CHRNA1, CHRNA6 PTPN1 2063/4885PTPRF 2718/4885MAPT 1079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.